MITOXANTRONE (N) VS. 5-FLUOROURACIL EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC)AS FIRST LINE THERAPY IN HIGH-RISK METASTATIC BREAST-CANCER/

Authors
VONMINCKWITZ G HEIDEMANN E SOUCHON R SAMONIGG H HIRSCHMANN WD BODENSTEIN H SCHINDLER A SCHULZE M CLEMENS H KONIG M SCHARL A FISCHER JT KAUFMANN M
Citation
G. Vonminckwitz et al., MITOXANTRONE (N) VS. 5-FLUOROURACIL EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC)AS FIRST LINE THERAPY IN HIGH-RISK METASTATIC BREAST-CANCER/, European journal of cancer, 33, 1997, pp. 646-646
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
646 - 646
Database
ISI
SICI code
0959-8049(1997)33:<646:M(V5E(>2.0.ZU;2-K